Skip to content

Drugsformulations

  • RISK Assessment
  • TABLET
  • ORAL LIQUID
  • CAPSULE
  • SACHETS
  • DRY SYRUP
  • EYE /EAR DROPS
  • INJECTIONS
  • OINTMENT
  • QA
    • Qualifications & Validations
    • SOPs
    • JOBS
      • Current Interview Search
  • Toggle search form

MASTER FORMULA OF PHENYLEPHERINE HYDROCHLORIDE,CETRAZINE DIHYDROCHLORIDE ,ARACETAMOL & CAFFEINE ANHYDROUS TABLETS

Posted on August 8, 2020December 15, 2024 By ABHA

Phenylephrine Hydrochloride, Cetirizine Dihydrochloride, Paracetamol, and Caffeine Anhydrous Tablets: Uses, Dosage, and Safety

Phenylephrine hydrochloride, cetirizine dihydrochloride, paracetamol, and caffeine anhydrous tablets are a commonly used combination medication for the relief of allergy symptoms, nasal congestion, pain, and fever. This comprehensive guide aims to provide a detailed understanding of these tablets, including their uses, dosage, side effects, and safety considerations. Whether you’re a patient or a healthcare professional, this guide will equip you with the knowledge needed to make informed decisions regarding the usage of these tablets.

Understanding Allergies and Common Cold

Types of Allergic Reactions and Symptoms

1.2 Causes and Triggers of Allergies

1.3 Common Cold: Symptoms and Duration

Introduction to Phenylephrine Hydrochloride, Cetirizine Dihydrochloride, Paracetamol, and Caffeine Anhydrous Tablets

2.1 What are These Combination Tablets?

2.2 Mechanism of Action of Each Component

2.3 Available Brands and Forms of These Tablets

Medical Uses of the Combination Tablets

3.1 Relief of Allergy Symptoms

3.2 Nasal Congestion Relief

3.3 Pain and Fever Management

3.4 Off-Label Uses of the Combination Tablets

Dosage and Administration

4.1 Recommended Dosage for Different Age Groups

4.2 Dosage Forms and Strengths of the Combination Tablets

4.3 Administration Techniques and Instructions

4.4 Monitoring and Adjusting Dosage

Potential Side Effects and Precautions

5.1 Common Side Effects of the Combination Tablets

5.2 Rare but Serious Side Effects

5.3 Precautions and Contraindications

5.4 Drug Interactions with the Combination Tablets

Safety Considerations and Special Populations

6.1 Safety Guidelines for Pregnant and Breastfeeding Women

6.2 Use of the Combination Tablets in Pediatric Patients

6.3 Geriatric Considerations and Dosage Adjustments

6.4 Managing the Combination Tablets in Patients with Comorbidities

Monitoring and Management

7.1 Regular Check-ups and Follow-up Appointments

7.2 Assessing Treatment Response and Adjusting Therapy

7.3 Adherence and Self-Monitoring Recommendations

Lifestyle Considerations and Self-Care

8.1 Environmental Allergen Control Measures

8.2 Pain and Fever Management Techniques

8.3 Educating Others about Allergies and Medication Usage

Frequently Asked Questions about the Combination Tablets

9.1 Can These Tablets Cure Allergies or the Common Cold?

9.2 How Long Can These Tablets Be Used?

9.3 Are These Tablets Safe for Long-Term Use?

9.4 Can These Tablets Be Used with Other Medications?

Emerging Trends and Future Directions

10.1 Advances in Allergy and Cold Symptom Relief

10.2 Development of Targeted Therapies for Allergies and Pain Relief

10.3 Patient Education and Allergy Awareness Programs

Conclusion

Phenylephrine hydrochloride, cetirizine dihydrochloride, paracetamol, and caffeine anhydrous tablets provide relief from a range of symptoms, including allergies, nasal congestion, pain, and fever. By understanding their uses, dosage, potential side effects, and safety considerations, patients and healthcare professionals can make informed decisions regarding their therapy. Adherence to the recommended dosage, precautions, and regular monitoring are crucial for successful treatment outcomes. Additionally, incorporating lifestyle measures and promoting allergy and pain management techniques can contribute to overall well-being. With this comprehensive guide, you are equipped with the knowledge needed to navigate the world of these combination tablets confidently.

MANUFACTURING PROCEDURE OF PHENYLEPHRINE HYDROCHLORIDE, CETRAZINE DIHYDROCHLORIDE, PARACETAMOL & CAFFEINE ANHYDROUS TABLETS

PURPOSE:  This Master Formula is written to describe the formulae, manufacturing procedure, specifications, and packing details of the dosage form.

SCOPE: This MFR is performed and is applied during the manufacturing of dosage form.

RESPONSIBILITY / ACCOUNTABILITY: It is the responsibility of the Manufacturing Chemist to follow and adhere to this SOP. The Production Pharmacist and QC/QA Manager are accountable for the strict adherence to the master formula.

PRODUCT NAME: 

PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE DIHYDROCHLORIDE, PARACETAMOL & CAFFEINE ANHYDROUS TABLETS, BATCH SIZE:  500000

EXPIRY DATE: AFTER 27 MONTHS   FROM THE DATE OF MANUFACTURING

COMPOSITION: Each uncoated Tablet contains:

PHENYLEPHRINE HYDROCHLORIDE         B.P.        5 mg

CETRAZINE DIHYDROCHLORIDE                  B.P.       2 mg

PARACETAMOL                                                B.P.      500 mg

CAFFEINE ANHYDROUS                                  B.P.      15 mg

COLOUR: PONCEAU 4 R

EQUIPMENT TO BE USED:

Steam Jacketed Starch Paste Preparation Tank
Sifter Machine
Roto Cube Blender
Rapid Mixer Granulator
Multi Mill
Fluidized Bed Drier
Oscillating Granulator
Sifter Machine
Roto Cube Blender
Tablet Compression Machine 27 Stations
Dedusting Machine
Tablet Inspection Machine

RAW MATERIAL:-

INGREDIENTS Overages %Total Quantity Used
Phenyl Epherine Hydrochloride2.00 2.625  kgs.
D.C.P.8.000 kgs
Lactose5.000 kgs
Magnesium Stearate1.500 kgs
Sodium Benzoate0.500 kgs
PVPK-300.800 kgs
Starch16.00 kgs
Starch0.500 kgs
Starch5.000 kgs
Ponceu- 4R Colour25.000 kgs
Talcum3.000 kgs
Aerosil0.500 kgs
Caffeine Anhydrous57.875 kgs
Paracetamol5262.500 kgs
Cetrazine Hydrochloride51.050 kgs

PACKING MATERIALS:-   

NAME OF THE MATERIAL TOTAL QUANTITY USED
ADHESIVE TAPE ROLL BROWN1.0 NOS
 4 TAB UNIT CARTON13095.00 NOS
 50 X 4 TAB OUTER CARTON260.00 NOS
C.BOX  (470 X460 X 465)5.00 NOS
 CELL TAPE ROLL1.00 NOS
CUREFLU STRIP FOIL (BACK) SILVER1.00 KGS
STRIP FOIL  (BACK) TRANSPARENT1.00 KGS
CUREFLU STRIP FOIL(FRONT) SILVER1.00 KGS
 STRIP FOIL  ((FRONT) TRANSPARENT1.00 KGS

MANUFACTURING SPECIFICATION:

The moisture content of powder should be less than 2.0 %.

Average weight of each Tablet 600 mg. Weight Variation Limit for average weight of 20 tablets is + 5 %.

Friability limit for 10 Tablets is not more than 1.0 %.

Hardness of the Tablets varies between 2-4 kg/cm2.

Disintegration time for each Tablet is not more than 30 minutes.

Mix the batch, compress and de-dust the tablets and also perform the primary packing of Tablets at temperature not more than 25˚ C.

Yield:

Theoretical Yield 500000 Tablets.

Expected Practical Yield is 500000 ± 5 %

Packing Details:

Use Aluminium strip for strip packing.

Strip Pack the inspected and De-dusted tablets by using a Strip Packing Machine.

Put 1 strip each containing 4 tablets in each unit carton along with the literature and applicator.

Put such 10 unit cartons in each outer carton.

Seal each outer carton from both ends with cello tape.

Pack 30 outer cartons in a specified Box to give a pack size of  20 x 50 x 4  tablets.

Seal the each corrugated box with adhesive tape and label it properly by affixing the specified label

MANUFACTURING PROCESS:

Preparation of Starch Paste:

Prepare the starch paste in the manner given below using a Steam Jacketed Starch Paste Preparation Tank by operating it Dissolve 0.030 kg of M.P.B.S and 0.010 kg of P.P.B.S in 1Ltr of Purified water and stir continuously.

Add 4.0 kgs of Starch in 4 Ltrs of Purified water and stir continuously to make a smooth slurry.

Take 40 Ltrs of boiling water and add the solution of M.P.B.S and P.P.B.S and starch slurry with constant stirring to get a uniform paste. 

Sifting:

Fit Stainless Steel Sieve #40 on the Sifter. Sift all the ingredients through it and collect them separately in Stainless Steel Containers. 

Blending:

Blend the following ingredients using the Roto Cube Blender by operating it for 60 minutes and collect in a Stainless Steel Container.

  • 10.20 kg of Mebendazole
  • 1.00 kg of Lactose.
  • 1.00 kg of Di Calcium Phosphate

Wet Granulation:

Mix the above-blended ingredients with the Starch paste using the Rapid Mixer Granulator by operating it, Add the starch paste in such a manner by following the procedure given below to achieve proper wetting.

Mix the blended powder and starch paste in the Rapid Mixer Granulator.

Wet Screening:

Pass the wet dough through a Multi Mill by operating it to convert the moist mass into coarse, granular aggregates.

Drying:

Dry the granules in a Fluidized Bed dryer by operating it at temperatures of 600 to 700 C for 30 minutes. Cool the granules to room temperature. Repeat the same process for the next lots.

Sifting:

Fit Stainless Steel Sieve # 20 on the Sifter. Sift all the ingredients through it and collect them in a Stainless Steel Container. Break the oversized granules left over the mesh in the Oscillating Granulator by operating it and resifting them.

Check the total weight of dried granules. Determine the loss on drying and the percentage yield of dried granules. 

Lubrication:

Add the following lubricating agents to the Roto Cube Blender and operate it for 30 minutes. Collect the blended powder in Stainless Steel Container

  • 0.200 kgs of Talcum
  • 0.050 kgs of Magnesium Stearate
  • 0.500 kgs of starch
  • 0.025 kgs of Aerosil

Send the granules for bulk testing to the Quality Control Department for assay of Active Ingredients.

Compression:

Shift all the granules for compression to Tablet Compression Machine 27 Stations by operating it and collecting the compressed tablets in a Stainless Steel Container.

Inspection:

Transfer all the tablets to the tablet inspection machine and sort out the defective tablets by operating it as per their SOP  and collect the selected tablets in a Stainless Steel Container. 

Strip Packing:         

Shift the inspected tablets to the packing section and strip pack them using the Strip Packing Machine by operating it as per its SOP.

Weight Variation: I) Intermittently weight variation of compressed tablets should be checked at 30-minute intervals by the Assistant Manufacturing Chemist and a record for the same should be kept in the Batch Manufacturing Record

Out-of-limit tablets should be checked by the Weight Variation Method.

Take the average weight of 20 tablets on the calibrated balance and calculate the upper and lower limit as per below by IP/BP/USP:

Take the weight of individual tablets and check if all the tablets are lying within the limits.

Select the tablets only if no more than two tablets are out of the percentage limit and if no tablet differs by more than two times the percentage limit, otherwise reject the tablets.

Adjust the desired weight of the tablets in the Compression Machine by moving the weight adjustment cam clockwise or anticlockwise accordingly as per the Standard Operating Procedure of the Compression Machine.

Re-check the weight of tablets for further adjustment, if any.

The thickness of Tablets: The thickness of the tablets should be determined using the vernier caliper. The thickness of the tablet should be checked whenever weight adjustments are made.

Hardness of the tablets: The equipment used is the ‘Monsanto’ type hardness tester. The hardness of the compressed tablets should be checked at regular intervals to determine the need for pressure adjustments on the tableting machine.

The hardness of tablets varies between 2-4 Kg/cm2.

Friability:

Roche Friabilator is used for measuring the Friability. The instrument is designed to evaluate the ability of the tablet to withstand abrasion in packaging, handling, and shipping.

Adjust the instrument to 25 RPM before adding the tablets.

Weigh 20 Tablets on a calibrated balance. Transfer the tablets to the plastic chamber. Close the drum tightly.

Switch on the apparatus. Operate the Friabilator for 100 revolutions.

De-dust and reweigh the tablets. Loss in weight indicates the ability of tablets to withstand wear.

Take 10 tablets to check the friability, when the average weight of the tablet is 1g or more than 1g.

 Friability Limit  = Less than 1.0%

Disintegration Test:

Disintegration is the time required for the group of tablets to disintegrate into the particles. Disintegration Test should be carried out at regular intervals of 1 hour by using the Disintegration Test Apparatus.

The tube assembly unit is removed from the glass beaker and from each tube the plastic discs are removed.

Place the tablets in each of the 6 tubes along with a plastic disc over the tablets.

The glass beaker is filled with water. The water in the beaker is retained at the temperature of 37+1˚C throughout the test by suitably setting the thermostat.

Introduce a tube assembly unit into a glass beaker in such a way that the wire mesh at the base of each tube is at least 2.5cm below the surface of the liquid when the basket is at its highest position.

Switch on the apparatus to move the basket assembly containing the tablets up and down through a distance of 5 to 6 cm at a frequency of 28 to 32 cycles per minute. Start the stopwatch.

When the tablets have disintegrated i.e. when no particles remain on the wire mesh at the bottom of the tube, stop the stopwatch. Note the time taken for the disintegration of the tablets and record the same in the Batch Manufacturing Record.

If one or two tablets fail to disintegrate, the test is to be repeated using 12 tablets

Disintegration Time of uncoated tablets= Not more than 15 minutes

Disintegration Time of coated tablets= Not more than 30 minutes

Tablets taken for testing and In-process control should not be added to the bulk batch to avoid mix-ups and cross-contamination.

Inspection and sorting of rejected tablets should be done.

The strips and cartons should be checked thoroughly for proper batch coding.

The Manufacturing Chemist and Production should randomly check that the correct no. of strips are being packed in each carton and also the number of cartons in each shipper is the same as that shown in the proof.

Intimation should be sent to the Quality Control Department for finished product sampling and testing.

After the completion of labeling and packaging, the coded cartons should be accounted for, and rejected printed material should be destroyed in the presence of the QC/QA Manager. Fill out the destruction sheet and attach the same in the Batch Manufacturing Record.

It will be ensured that filling or packaging equipment has been properly cleaned after the completion of the batch.

Packaging of the next product should not commence until the IPQA has given the ‘Line Clearance’

ANOTHER RELATED POST-MASTER FORMULA OF COMFORT EXPECTORANT

MASTER FORMULAS, Tablets Tags:Abu Dhabi, Agra, Agrigento, Ahmedabad, Ajman, Ajman and Ra’s al-Khaimah, Ajmer, Al Ain, Alberta, Alessandria, Aligarh, Allahabad, Amravati, Amritsar, Amsterdam, Amur, Ancona, Antwerp, Aosta, Arkhangelsk, Arlington, Ascoli Piceno, ashington, Ashland, Ashmore and Cartier Islands, Asti, Astrakhan, Athens, Auckland, Aurangabad, Australian Antarctic Territory, Australian Capital Territory, Austria, Avellino, Bangalore, Bangor, Barcelona, Bareilly, Bari, Barletta-Andria-Trani, Bavaria, Belarus, Belgium, Belgorod, Belgrade, Belluno, Benevento, Bergamo, Berlin, Bhavnagar, Bhilai Nagar, Bhiwandi, Bhopal, Bhubaneswar Salem, Biella, Bikaner, Birmingham, Birmingham (West Midlands), Bologna, Bradford, Bremen, Brescia, Brindisi, Bristol, British Columbia, Brussels-Capital Region, Bryansk, Bucharest, Budapest, Bulgaria, Burlington, Cagliari, Caltanissetta, Cambridge, Campobasso, canada, Canterbury, Carlisle, Caserta, Catania, Catanzaro, Centerville, Chandigarh, Charlottetown, Chelmsford, Chelyabinsk, Chennai, Chester, Chichester, Chieti, Christmas Island, Clayton, Cleveland, Clinton, Cocos (Keeling) Islands, Coimbatore, Como, Copenhagen, Coral Sea Islands, Cosenza, Coventry, Cremona, Crotone, Cuneo, Cuttack, Czech Republic, Dayton, Dehradun Garhwali, Delhi, denmark, Derby, Derry, Dombivali, Donetsk, Dover, dubai, Dublin, Durgapur Asansol, Durham, East Midlands, East of England, Edmonton, Ely, England, Enna, Exeter, Fairview, Faridabad, Fermo, Ferrara, Finland, Firozabad, Florence, Foggia, Forlì-Cesena, Frankfurt Rhine-Main Region, Franklin, Fredericton, Frosinone, Fujairah, Genoa, Georgetown, Germany, Ghaziabad, Glasgow, Gloucester, Gorakhpur, Gorizia, Greater Glasgow, Greater London, Greater Manchester, greece, Greenville, Grosseto, Gujarati, Gulbarga, Guntur, Gurgaon, Guwahati, Gwalior, Halifax, Hamburg, Haora, Hawke's Bay, Heard Island and McDonald Islands, Helsinki, Hereford, Hesse, Hubli and Dharwad, Hudson, Hungary, hyderabad, Imperia, Indore, Iqaluit, ireland, Irkutsk, Isernia, Istanbul, Italy, Ivanovo, Jabalpur, Jackson, Jaipur, Jalandhar, Jammu, Jamnagar, Jamshedpur, Jervis Bay Territory, Jhansi, Jodhpur, Kaliningrad, Kaluga, Kalyan, Kanpur, Katowice urban area, Kazan, Kemerovo, Kharkiv, Kiev, Kingston, Kirov, Kochi, Kolkata, Kostroma, Kota, Kraków, Kurgan, Kursk, L'Aquila, La Spezia, Lancaster, Latina, Lebanon, Lecce, Lecco, Leeds, Leicester, Leningrad, Lexington, Lichfield, Lille–Kortrijk–Tournai France/ Belgium, Lincoln, Lipetsk, Lisbon, Lisburn, Liverpool, Livorno, london, Loni, Lucca, Lucknow, Ludhian, Macerata, Madison, Madrid, Madurai, Magadan Moscow, Manchester, Manitoba, Mantua, Marlborough, Marseille, Massa and Carrara, Matera, Meerut, Messina, Milan, Milford, Milton, Minsk, Modena, Monza and Brianza, Moradabad, Moscow, Mount Vernon, Mumbai, Murmansk, Mysore, Nagpur, Nanded Kolapur, Naples, Nashik, Navi Mumbai, Nellore, Nelson, Netherlands, New Brunswick, New Plymouth, New South Wales, Newfoundland and Labrador, Newport, NewportAuburn, Nizhniy Novgorod, Nizhny, Noida, Norfolk Island, North East, North West, Northern Ireland, Northern Territory, Northwest Territories, Norway, Norwich, Nottingham, Nova Scotia, Novara, Novgorod, Novosibirsk, Nunavut, Nuoro, Nuremberg, Oakland, Omsk, Ontario, OntarioToronto, Orenburg, Oristano, Oryol, Otago, Ottawa, Oxford, Padua, Palermo, Paris, Parma, Patna, Pavia, Penza, Perth, Perugia, Pesaro and Urbino, Pescara, Peterborough, Piacenza, Pimpri, Pisa, Pistoia, Plymouth, Poland, Pordenone, Porto Portugal, Portsmouth, portugal, Potenza, Prague, Prato, Preston, Prince Edward Island, Pskov, Pune, Quebec, Quebec City, Queensland, Ragusa, Raipur, Rajkot, Ranchi, Ras Al Khaimah, Ravenna, Reggio Calabria, Reggio Emilia, Regina, Rieti, Rimini, Ripon, Riverside, Romania, Rome, Rostov, Rotterdam, Rovigo, Russia, Ryazan, Saharanpur, Saint Petersburg, Sakhalin, Salem, Salerno, Salford, Salisbury, Samara, Saratov, Saskatchewan, Sassari, Savona, Saxony, Scotland, Serbia, Seville, Sharjah, Sheffield, Siena, Siliguri, Smolensk, Sofia, Solapur, Sondrio, South Australia, South East, South Sardinia, South Tyrol, South West, Southampton, Southland, spain, Springfield, Srinagar, St Albans, St Asaph, St Davids, St. John’s, Stirling, Stuttgart, Sunderland, Surat, Sverdlovsk, Swansea, Sweden, switzerland, Syracuse, Tambov, Taranto, Tasmania, Teramo, Terni, Thane, The Hague, Thiruvananthapuram, Thuringia, Tiruchirappalli, Tomsk, Trapani, Trento, Treviso, Trieste, Truro, Tula, Turin, turkey, Tver, Tyumen, Udine, Ujjain, Ukraine. Dnipropetrovsk, Ulhasnagar, Ulyanovsk, Umm al-Qaiwain, Umm al-Quwain, United arab emirates, united Kingdom, United States, Vadodara, Valencia, Varanasi, Varese, Vasai Virar, Venice, Verbano-Cusio-Ossola, Vercelli, Verona, Vibo Valentia, Vicenza, Victoria, Vienna, Vijayawada, Visakhapatnam, Viterbo, Vladimir, Volgograd, Vologda, Voronezh, Wakefield, Wales, Warsaw, Wellington, Wells, West Midlands, West Yorkshire (Bradford–Leeds), Western Australia, Westland, Whitehorse, Winchester, Winnipeg, Wolverhampton, Worcester, Yaroslavl, Yellowknife, York, Yorkshire and the Humber, Yukon, Zürich

Post navigation

Previous Post: Master formula Thiamine Mono-Nitrate,Riboflavine and Pyridoxine Hydrochloride Capsules
Next Post: MASTER FORMULA OF DIPHENHYDRAMINE AND AMMONIUM CHLORIDE EXPECTORANT

More Related Articles

MFR of Paracetamol Oral Suspension IP (125 mg) Tablets
MFR of Ferric Ammonium Citrate & Folic Acid Syrup Oral Liquid
Salbutamol Tablets: Uses, Dosage, and Safety MASTER FORMULAS
Metformin Hydrochloride Tablet 500 mg Tablets
Tetracycline hydrochloride I.P. 500 mg Capsules
DICLOFENAC SODIUM GEL MASTER FORMULAS




Recent Posts

  • Get started now and luxuriate in some great benefits of sugar daddy chat rooms
  • Get started with gay black hookups today
  • Something Sex Chat Roulette consequently they are These Types Of Services Popular? Examine My Record and Find Your Chosen.
  • How to obtain the perfect sugar momma hookup
  • Find your perfect match – black christian singles




Categories

  • Blender
  • Blister Machine
  • Capsules
  • Compression Machine
  • DRY POWDER
  • Dry Syrup
  • EXTERNAL PREPARATION
  • EYE /EAR DROPS
  • Injections
  • MASTER FORMULAS
  • OINTMENT
  • Ointments
  • Oral Liquid
  • Qualifications & Validations
  • Quality Assurance
  • RISK Assessment
  • SOPs
  • Tablets
  • Uncategorized
  • Validation




Recent Posts

  • Get started now and luxuriate in some great benefits of sugar daddy chat rooms
  • Get started with gay black hookups today
  • Something Sex Chat Roulette consequently they are These Types Of Services Popular? Examine My Record and Find Your Chosen.
  • How to obtain the perfect sugar momma hookup
  • Find your perfect match – black christian singles




Archives

  • May 2025
  • April 2025
  • March 2025
  • November 2024
  • March 2024
  • February 2024
  • December 2023
  • November 2023
  • October 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • February 2023
  • January 2023
  • December 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • RISK Assessment
  • TABLET
  • ORAL LIQUID
  • CAPSULE
  • SACHETS
  • DRY SYRUP
  • EYE /EAR DROPS
  • INJECTIONS
  • OINTMENT
  • QA
    • Qualifications & Validations
    • SOPs
    • JOBS
      • Current Interview Search




Recent Jobs

Bliss GVS Pharma Ltd-Vacancies for M.Pharm, B.Pharm, MSc in QA, QC, Production Apply

More Details

Zydus Lifesciences -Walk In Interview on 19th March 2025

More Details

Ipca -Walk In Interview For QA/ QC and Maintenance Dept on 23/03/2025

More Details

Torrent Pharma-Walk In Drive for M.Pharm, MSc as ADL Executive on 23rd MARCH, 2025

More Details

Gufic Biosciences-walk in for B.Pharm, MSc, BSc in Quality Control, Production on 22/03/2025 

More Details

Intas- Walk In Interview For Fresher on 22nd March 2025 

More Details

Indeed Jobs-Symed Labs Ltd (Viyash Life Sciences) – Walk-In Drive for Quality Control / Quality Assurance / EHS / ETP on 17th-21st Dec’ 2024

More Details

Indeed Jobs- Siflon Drugs & Pharmaceuticals Pvt. Ltd -Interview on 17th & 18th Dec’ 2024

More Details

Indeed Jobs SRF- Walk In Interview For Multiple Openings on 17th December 2024

More Details

Indeed Jobs Bafna Pharmaceuticals Walk-In Interview on 22nd December 2024.

More Details

Copyright © 2025 Drugsformulations.

Powered by PressBook Green WordPress theme

Do Not Sell My Personal Information
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT